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Background: Neck circumference (NC) is a predictor of cardiometabolic risk. The
objective of this study was to explore the relationship of NC to muscle sympathetic nerve
activity (MSNA) within an overweight and obese population.
Methods: The study design was a retrospective cross-sectional analysis. Un-medicated
persons (72 men, 53 postmenopausal women) aged 56 ± 1 years (mean ± SEM) with
body mass index (BMI) 32.8 ± 0.4 kg/m2, were studied. NC was measured together
with traditional anthropometric measures, supine blood pressure, fasting blood lipids,
insulin, and glucose. Insulin sensitivity was assessed by homeostasis model (HOMA-IR)
and Matsuda Insulin Sensitivity Index (ISI) derived from 75-g oral glucose tolerance test.
Resting multiunit MSNA was recorded by microneurography in the peroneal nerve and
expressed as burst frequency and burst incidence.
Results: Men within the highest tertile of NC had significantly higher fasting and
post-glucose plasma insulin levels (insulin AUC0−120), HOMA-IR, non-esterified fatty
acids, MSNA (45 ± 2 vs. 36 ± 2 bursts per min; 69 ± 3 vs. 58 ± 3 bursts per 100 hb)
and heart rate, and lower Matsuda ISI compared to men in the lowest tertile (P all<0.05).
In stepwise regression analyses, NC alone explained 12%, and together with insulin
AUC0−120 it accounted for 22%, of the variance in MSNA in men. In women, NC was
associated with anthropometric measures but not with MSNA or metabolic indices.
Conclusions: Among overweight and obese men, NC was independently associated
with elevated MSNA and hyperinsulinemia, and thus may be relevant to cardiometabolic
risk prediction. The biological basis of gender differences merits further elucidation.
Keywords: neck circumference, sympathetic nervous system activity, obesity, gender differences, metabolic
syndrome, cardiovascular risk, insulin resistance
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INTRODUCTION
Excess upper-body adiposity, particularly in the visceral region,
confers increased risk of developing metabolic syndrome,
type 2 diabetes and cardiovascular disease (Neeland et al.,
2012; Abraham et al., 2015). Since neck fat compartments
expand with increasing adiposity, interest has focused on the
utility of neck circumference (NC), a simple anthropometric
measurement and proxy for upper-body subcutaneous fat, to
predict cardiometabolic risk (Torriani et al., 2014). Imaging
studies have established that neck adipose tissue quantified
by computed tomography correlates positively with abdominal
visceral fat and cardiovascular risk factors, and is predictive
of metabolic syndrome and obstructive sleep apnea severity
(Karimi et al., 2010; Li et al., 2014; Torriani et al., 2014). In
large population studies, such as the Framingham Heart Study
and the Brazilian Longitudinal Study of Adult Health (ELSA-
Brasil), NC was positively associated with cardiovascular risk
factors and subclinical atherosclerosis, even after adjustment
for visceral adipose tissue and/or body mass index (BMI)
(Preis et al., 2010; Baena et al., 2016). This suggests that fat
accumulation in the neckmay confer risk beyond visceral adipose
tissue accumulation. Moreover, in longitudinal analyses, NC was
predictive of incident type 2 diabetes in the Framingham cohort,
and of future cardiovascular events and all-cause mortality in
high-risk cardiology outpatients (Preis et al., 2013; Dai et al.,
2016).
Elevated sympathetic nervous system (SNS) activity is
a characteristic of obesity that relates to a number of
pathogenic factors including central body fat distribution,
hyperinsulinemia secondary to insulin resistance, baroreflex
impairment, and the presence of obstructive sleep apnea (OSA)
(Narkiewicz et al., 1998a; Beske et al., 2002; Grassi et al.,
2004). Chronic sympathetic activation promotes unfavorable
alterations in cardiovascular structure and function (e.g., arterial
stiffening, cardiac enlargement, diastolic dysfunction, glomerular
hyperfiltration) and decreased insulin sensitivity, via both blood
pressure dependent and independent effects. Consequently, it is
an important mediator of target organ damage and metabolic
risk in both obese and hypertensive states (Masuo et al.,
1997; Schlaich et al., 2015). To our knowledge, no study to
date has examined the relationship of NC to SNS activity,
which may be of relevance to cardiovascular risk stratification.
Therefore, the aim of the present study was to perform gender-
specific cross-sectional analyses to determine whether NC is
independently associated withmuscle sympathetic neural activity
(MSNA) in overweight and obese subjects. The technique of
microneurography was used to directly quantify efferent post-
ganglionic sympathetic outflow directed to skeletal muscle
vasculature in the lower leg.
METHODS
Study Population
Subjects participating in clinical trials of weight loss and
pharmacological insulin-sensitization, during the period 2003–
2014 (registered as NCT00163943, NCT00408850, and NCT
01771042), who had both NC and MSNA measurements
at baseline, were included in the present analysis. Selection
criteria and experimental methodologies were similar across
all trials. Subjects were recruited from the general population
via newspaper advertisements and telephone screening. Entry
criteria were: non-smoker, aged 45–70 years, with a BMI
>27 kg/m2 and weight stable (± 1 kg) in the previous
6 months. Females were postmenopausal. Exclusion criteria
comprised history of cardiovascular, cerebrovascular, renal, liver,
or thyroid diseases; use of continuous positive airway pressure
treatment; and consumption of medications that could affect
study parameters (e.g., oral hypoglycemics, cholesterol-lowering,
anti-hypertensive, anti-depressant and hormone replacement
therapies). All participants signed an informed, witnessed,
consent form. Study protocols were approved by the Alfred
Hospital Human Research Ethics Committee.
Clinical Investigations
Participants attended our clinical research unit at 8 am, having
fasted overnight and abstained from caffeine for 18 h and
alcohol and heavy exercise for 36 h. Body weight was measured
in light indoor clothing and bare feet, using a digital scale.
Waist and hip circumferences were measured at the midpoint
between the lowest rib and the iliac crest and at the greater
trochanter, respectively. NC was measured with a flexible plastic
tape, with subjects standing upright and their head in the
Frankfort horizontal plane. Measurements were made in the
midway of the neck, just below the laryngeal prominence (Ben-
Noun et al., 2001). Supine resting blood pressure was recorded
as the average of 5 readings after 5 min rest using a Dinamap
monitor (Model 1846SX, Critikon Inc, Tampa, FL, USA). Fasting
venous blood was drawn for the measurement of lipid profile,
glucose and insulin, biochemistry, liver function tests, non-
esterified fatty acids (NEFA), leptin, high-sensitivity C-reactive
protein (hs-CRP) and plasma renin activity (PRA). Presence of
metabolic syndrome components were determined according to
the harmonized definition, using waist circumference cut-points
of ≥102 cm in men and ≥88 cm in women (Alberti et al., 2009).
Assessments of MSNA, cardiac baroreflex sensitivity (BRS)
and oral glucose tolerance were performed together on the same
morning, in the supine position, in a temperature controlled
(22◦C) research room. Subjects voided prior to commencement.
A tungsten microelectrode (FHC, Bowdoinham, ME, USA) was
inserted into the right peroneal nerve at the fibular head (Vallbo
et al., 2004). A subcutaneous reference electrode was positioned
2 to 3 cm away from the recording site. Standard criteria were
used to ascertain a MSNA site. The nerve signal was amplified
(X50,000), filtered (bandpass, 700 to 2,000 Hz), and integrated.
Intra-arterial blood pressure, ECG, respiration and MSNA were
digitized with a sampling frequency of 1,000 Hz (PowerLab
recording system, model ML 785/8SP, ADI Instruments). Resting
measurements were recorded over a 15-min period and averaged.
Sympathetic bursts were counted manually and expressed as
burst frequency (bursts/min) and burst incidence (bursts/100
heart beats). Spontaneous cardiac BRS was assessed by the
sequence method (Parati et al., 2004). The slope of the
regression line between cardiac interval and systolic blood
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pressure was calculated for validated sequences of three or
more consecutive heartbeats in which systolic blood pressure
progressively increased and cardiac interval lengthened (type 1
sequence) or systolic blood pressure progressively decreased and
cardiac interval shortened (type 2 sequence), with a lag of 1 beat.
Recordings were averaged over a 15-min period of supine rest.
After completion of microneurography, subjects underwent
a standard 75-g oral glucose tolerance test (OGTT, Glucaid,
Fronine PTY, LTD, Taren Point, NSW 2229, Australia) with 30-
min intravenous blood sampling for determination of glucose
and insulin responses. Homeostasis model assessment of insulin
resistance (HOMA-IR) and the Matsuda insulin sensitivity
index (ISI) were calculated as indices of insulin resistance and
sensitivity, respectively (Matthews et al., 1985; Matsuda and
DeFronzo, 1999). The insulinogenic index (1 insulin 0–30 min
divided by 1 glucose 0–30 min) was used to assess pancreatic
β-cell function.
Laboratory Measurements
Plasma glucose and lipid profile were measured on a
commercial analytical system (Architect C18000 analyzer,
Abbott Laboratories, Illinois, USA). Hs-CRP was quantified
by immunoturbidimetric assay, insulin, leptin and PRA by
radio-immuno assay (Linco Research, Inc, Missouri, USA; REN-
CT2, CIS bio international, France), and NEFA by enzymatic
colorimetry (Wako Pure Chemical Industries, Ltd, Osaka,
Japan).
Statistical Analysis
Statistical analysis was performed using SigmaStat Version 3.5
(Systat Software Inc, Point Richmond, CA, USA). Data are
presented as the mean ± SEM for normally distributed data
and as the median [interquartile range] for nonparametric data.
Data frommen and women were separately stratified into tertiles
of NC. Comparisons of MSNA, anthropometric, metabolic and
cardiovascular parameters across tertiles were made by one-
way ANOVA and Kruskal-Wallis one-way ANOVA on ranks, as
appropriate. The Holm-Sidak test was used to adjust for multiple
comparisons. Univariate associations between MSNA and other
variables were assessed using Pearson’s correlations. Non-
parametric data were log-transformed. Forward stepwise linear
regression analysis, was performed to determine whether NC
TABLE 1 | Demographic and clinical data in relation to neck circumference tertile in men.
Variable Tertile 1 (n = 24) Tertile 2 (n = 24) Tertile 3 (n = 24) P
Neck circumference (cm) 40.5 ± 0.3 43.4 ± 0.1*** 46.9 ± 0.5***‡ <0.001
Age (yrs) 54 ± 1 56 ± 1 53 ± 1 0.18
Weight (kg) 91.9 ± 1.7 101.2 ± 2.3** 118.6 ± 3.0***‡ <0.001
BMI (kg/m2) 29.9 ± 0.4 32.5 ± 0.5** 36.7 ± 0.9***‡ <0.001
Waist circumference (cm) 104.6 ± 1.2 111.2 ± 1.6** 121.9 ± 2.1***‡ <0.001
Waist: Hip ratio 0.97 ± 0.01 0.98 ± 0.01 0.99 ± 0.01 0.13
Leptin (ng/ml) 6.3 (5.2, 10.1) 7.1 (6.1, 11.9) 9.6 (6.7, 19.5) 0.09
LDL-cholesterol (mmol/L) 3.6 ± 0.2 3.1 ± 0.1 3.3 ± 0.2 0.08
HDL-cholesterol (mmol/L) 1.00 (0.90, 1.15) 1.05 (1.00, 1.20) 1.10 (0.90, 1.20) 0.88
Triglycerides (mmol/L) 1.4 (0.9, 2.1) 1.4, (1.2, 2.1) 1.8 (1.3, 2.6) 0.18
NEFA (mEq/L) 0.43 ± 0.03 0.40 ± 0.03 0.51 ± 0.03*‡ 0.02
Hs-CRP (mg/L) 1.7 (1.2, 4.9) 1.7 (1.3, 2.7) 2.9 (2.1, 4.7) 0.11
ALT (mU/L) 25 (21, 30) 28 (22, 45) 30 (26, 40) 0.17
GGT (mU/L) 34 (29, 45) 33 (23, 58) 31 (25, 48) 0.66
Fasting glucose (mmol/L) 5.6 ± 0.1 6.0 ± 0.1* 5.8 ± 0.1 0.048
Fasting insulin (mU/L) 13.4 ± 1.1 16.4 ± 1.4 19.9 ± 1.4*** 0.003
HOMA-IR 3.37 ± 0.28 4.48 ± 0.41 5.14 ± 0.36*** 0.003
2-h glucose (mmol/L) 9.1 ± 0.5 10.1 ± 0.6 9.8 ± 0.4 0.31
Insulin AUC0−120 (mU min L
−1) 8608 ± 619 9112 ± 842 11903 ± 1169* 0.03
Matsuda ISI 2.54 (2.20, 3.35) 2.09 (1.70, 3.09) 1.87 (1.41, 2.22)*** 0.001
Insulinogenic index (mU insulin mmol−1 glucose) 14.9 (9.4, 23.1) 15.3 (9.3, 21.6) 17.8 (12.4, 29.9) 0.22
Systolic BP (mmHg) 132 ± 3 133 ± 3 130 ± 3 0.75
Diastolic BP (mmHg) 78 ± 2 78 ± 2 76 ± 2 0.69
Heart rate (bpm) 62 ± 2 59 ± 2 65 ± 2† 0.04
Cardiac BRS (msec/mmHg) 10.8 (6.7, 17.0) 13.7 (9.2, 16.0) 10.8 (7.7, 15.0) 0.44
PRA (ng/ml/h) 0.69 (0.32, 0.99) 0.76 (0.39, 1.22) 0.73 (0.32, 1.06) 0.86
MetS components (n) 2.5 (2.0, 3.0) 3.0 (2, 3.5) 3.0 (2.0, 4.0) 0.31
Values are mean ± SEM or median (IQ range). ALT, alanine aminotransferase; BP, blood pressure; BRS, baroreflex sensitivity; GGT, gamma-glutamyltransferase; HDL, high density
lipoprotein; HOMA-IR, homeostasis model assessment-insulin resistance; hs-CRP, high-sensitivity C-reactive protein; ISI, insulin sensitivity index; LDL, low-density lipoprotein; MetS,
metabolic syndrome, NEFA, non-esterified fatty acids; PRA, plasma renin activity. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. tertile 1;
†
P < 0.05,
‡
P < 0.01 vs. tertile 2.
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was independently associated with MSNA within each gender.
Statistical significance was accepted at the P < 0.05 (two-tailed)
level.
RESULTS
Of the 125 subjects studied, 72 were men and 53 were women.
The two genders had similar BMI, HOMA-IR, Matsuda ISI,
glucose tolerance, MSNA and cardiac BRS. However, the women
were significantly older (58 ± 1 vs. 54 ± 1 years), with
higher plasma HDL- and LDL-cholesterol, leptin and NEFA
concentrations, and lower alanine aminotransferase (ALT) and
gamma-glutamyltransferase (GGT) levels, body weight, waist
circumference, waist to hip ratio and NC compared to the men.
(P all< 0.01).
Tables 1, 2 summarize clinical and demographic data
according to NC tertiles in men and women, respectively.
Men within the highest tertile of NC had significantly higher
anthropometric indices, fasting and post-glucose plasma insulin
levels (insulin area under the curve, AUC0−120), HOMA-IR,
NEFA, and lower Matsuda ISI compared to men in the lowest
tertile (P all <0.05). Blood pressure and cardiac BRS did not
differ across NC tertiles. In women, BMI, waist circumference
and waist to hip ratio increased significantly across NC groups,
whereas metabolic and cardiovascular parameters did not differ
between tertiles. Figure 1 shows that men within the highest
NC tertile had significantly higher MSNA burst frequency (45
± 2 vs. 36 ± 2 bursts/min) and burst incidence (69 ± 3 vs.
58 ± 3 bursts/100 hb) compared to the lowest NC tertile. In
women MSNA did not differ between NC tertiles (lower panels,
Figure 1).
Table 3 summarizes univariate correlates of MSNA and NC.
In men, NC and insulin AUC0−120 were the strongest positive
correlates of MSNA. In women, age and plasma LDL-cholesterol
concentration were most closely associated with MSNA. In
adjusted stepwise regression analyses, NC alone explained 12% of
the variance in MSNA in men. Together with insulin AUC0−120,
NC explained 22% of the variability in men (Table 4). In
women, burst frequency was independently associated with
age and HOMA-IR, which explained 19% of the variance,
whilst burst incidence was independently associated with LDL-
cholesterol and HOMA-IR, together explaining 18% of the
variance (P < 0.05).
TABLE 2 | Demographic and clinical data in relation to neck circumference tertile in women.
Variable Tertile 1 (n = 18) Tertile 2 (n = 18) Tertile 3 (n = 17) P
Neck circumference (cm) 34.8 ± 0.3 37.1 ± 0.2*** 40.6 ± 0.4***‡ <0.001
Age (yrs) 59 ± 1 57 ± 1 59 ± 1 0.61
Weight (kg) 77.8 ± 2.2 87.9 ± 2.1** 96.3 ± 2.9***† <0.001
BMI (kg/m2) 30.5 ± 0.6 32.1 ± 0.6 35.1 ± 1.0***‡ <0.001
Waist circumference (cm) 93.4 ± 1.4 99.2 ± 1.4* 108.9 ± 2.5***‡ <0.001
Waist: Hip ratio 0.82 ± 0.01 0.85 ± 0.01 0.89 ± 0.01***‡ <0.001
Leptin (ng/ml) 21.6 (17.7, 24.6) 23.2 (15.4, 41.9) 25.0 (16.8, 31.0) 0.84
LDL-cholesterol (mmol/L) 4.1 ± 0.2 3.5 ± 0.2 3.6 ± 0.2 0.13
HDL-cholesterol (mmol/L) 1.35 (1.30, 1.60) 1.30 (1.20, 1.40) 1.30 (1.20, 1.43) 0.30
Triglycerides (mmol/L) 1.6 (1.4, 1.8) 1.2 (1.1, 1.6) 1.4 (1.0, 2.0) 0.22
NEFA (mEq/L) 0.59 ± 0.05 0.61 ± 0.04 0.63 ± 0.05 0.88
Hs-CRP (mg/L) 2.4 (1.0, 4.3) 2.4 (1.2, 3.3) 3.0 (1.7, 4.8) 0.56
ALT (mU/L) 19 (17, 25) 19 (15, 26) 25 (21,34) 0.08
GGT (mU/L) 22 (20, 38) 19 (16, 27) 22 (16, 31) 0.40
Fasting glucose (mmol/L) 5.7 ± 0.1 5.7 ± 0.1 5.6 ± 0.1 0.95
Fasting insulin (mU/L) 17.0 ± 1.1 17.4 ± 1.7 17.4 ± 1.1 0.97
HOMA-IR 4.29 ± 0.28 4.43 ± 0.43 4.44 ± 0.33 0.95
2-h glucose (mmol/L) 9.6 ± 0.4 9.9 ± 0.7 9.7 ± 0.6 0.94
Insulin AUC0−120 (mU min L
−1) 10,829 ± 1044 10,660 ± 827 11,668 ± 1008 0.75
Matsuda ISI 2.03 (1.81, 2.69) 2.11 (1.89, 2.56) 1.99 (1.49, 2.48) 0.88
Insulinogenic index (mU insulin mmol−1 glucose) 15.6 ± 2.0 16.5 ± 2.6 16.5 ± 1.8 0.95
Systolic BP (mmHg) 127 ± 4 125 ± 4 126 ± 4 0.98
Diastolic BP (mmHg) 72 ± 2 69 ± 2 69 ± 1 0.51
Heart rate (bpm) 64 ± 1 63 ± 2 61 ± 2 0.58
Cardiac BRS (msec/mmHg) 13.3 ± 1.7 16.1 ± 2.2 12.8 ± 1.3 0.35
PRA (ng/ml/h) 0.60 ± 0.09 0.61 ± 0.14 0.78 ± 0.13 0.53
MetS components (n) 3.0 (2.0, 3.0) 2.0 (2.0, 3.0) 3.0 (2.0, 4.0) 0.74
Values are mean ± SEM or median (IQ range). *P < 0.05, **P < 0.01 and ***P < 0.001 vs. tertile 1;
†
P < 0.05,
‡
P < 0.01 vs. tertile 2.
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FIGURE 1 | Microneurographic recordings of resting muscle sympathetic nerve activity (MSNA), expressed as burst frequency and burst incidence,
within tertiles of neck circumference in men (upper panels; A,B) and women (lower panels; C,D). *P < 0.05 and **P < 0.01 vs. tertile 1.
DISCUSSION
The present study investigated the association of NC, a potential
marker for upper body fat deposition, with resting sympathetic
neural activity in un-medicated middle-aged persons who were
overweight or obese. Findings indicated a dichotomy of effects
within the two genders. In men, NC was positively associated
with MSNA independent of age, blood pressure and other
adiposity measures such as waist circumference and BMI. In
women, NC was associated with anthropometric measures,
but did not delineate MSNA, metabolic or cardiovascular risk
factors. Our data suggest that hyperinsulinemia secondary to
decreased insulin sensitivity, gauged as elevated fasting and post-
glucose insulin AUC0−120, may be an intermediary mechanism
underlying the association between NC and MSNA in men. NC
was not associated with spontaneous cardiac BRS in either gender
in the present study.
Our findings concur with previously published data in
Caucasian and Asian populations, showing an association of
NC with classic obesity indices such as waist circumference
and BMI, and with insulin-resistance related factors (Laakso
et al., 2002; Zhou et al., 2013). More recent imaging studies
have highlighted that NC is positively correlated with visceral
adipose tissue and epicardial fat (Li et al., 2014; Küç¨uk et al.,
2016) and with subclinical and clinical atherosclerosis (Zen
et al., 2012; Baena et al., 2016). Our data further extend these
observations, by demonstrating for the first time that NC is
correlated with MSNA, a direct measure of central sympathetic
neural outflow to skeletal muscle, in men. Various pathogenic
mechanisms may be responsible for this association. Firstly,
hyperinsulinemia, which related to both NC and MSNA, is
known to elicit sympathetic activation via central and peripheral
mechanisms (Anderson et al., 1991; Kern et al., 2005). Centrally,
insulin’s effects are initiated in the arcuate nucleus and involve
various neural signaling pathways that mediate organ-specific
sympathetic outflows (Rahmouni et al., 2004; Cassaglia et al.,
2011). Peripherally, insulin may evoke a reflex increase in SNS
activity in response to its vasodilatory effects, albeit insulin-
induced sympathetic activation and vasodilation in skeletal
muscle are known to be blunted in obese humans (Vollenweider
Frontiers in Physiology | www.frontiersin.org 5 April 2017 | Volume 8 | Article 203
Straznicky et al. Neck Circumference and Sympathetic Activity
TABLE 3 | Univariate correlates of neck circumference and muscle sympathetic nerve activity (MSNA) within each gender.
Variables Men (n = 72) Women (n = 53)
Neck
circumference (cm)
MSNA
(bursts/min)
MSNA
(bursts/100 hb)
Neck
circumference (cm)
MSNA
(bursts/min)
MSNA
(bursts/100 hb)
Neck circumference (cm) 0.35** 0.26*
MSNA (bursts/min) 0.35**
MSNA (bursts/100 hb) 0.26*
Age (years) 0.33* 0.24
Body weight (kg) 0.73*** 0.74***
Body mass index (kg/m2) 0.74*** 0.24* 0.21 0.61***
Waist circumference (cm) 0.73*** 0.70***
Waist: Hip ratio 0.26* 0.50***
Log leptin (ng/ml) 0.34**
LDL-cholesterol (mmol/L) 0.28* 0.32*
Log triglycerides (mmol/L) 0.23*
NEFA (mEq/L) 0.21 0.26*
Log hs-CRP (mg/L) 0.26
Log ALT (U/L) 0.21 0.31**
Fasting insulin (mU/L) 0.31**
HOMA-IR 0.30* 0.23 0.26
Log Matsuda ISI −0.32** −0.26*
Insulin AUC0−120 (mU min L
−1) 0.23 0.35**
Diastolic BP (mmHg) 0.20
Heart rate (bpm) 0.26* 0.43*** 0.44***
Pearson correlation coefficients with P < 0.10 have been included in the table. *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001.
et al., 1994). Reverse causality may also be active, in that chronic
sympathetic activation per se may worsen insulin resistance
via hemodynamic and lipolytic effects, thus maintaining a
vicious bidirectional cycle (Jamerson et al., 1993; Masuo et al.,
1997). Interestingly, increasing adiposity was not associated with
worsening insulin sensitivity in the women participants of our
study.
Secondly, greater NC is associated with OSA syndromes
(Karimi et al., 2010; Lim et al., 2014) which are known to be
an important mediator of elevated sympathetic drive in obesity.
This is attributed to the stimulation of peripheral chemoreceptors
by the anoxia induced by nocturnal hypopneic-apnoeic episodes,
and also to diminished arterial baroreflex sensitivity in OSA
subjects (Narkiewicz et al., 1998b; Toschi-Dias et al., 2013).
The prevalence of OSA in newly diagnosed metabolic syndrome
subjects with similar clinical profile to our cohort, has been
reported at 60% (Drager et al., 2010). In the absence of formal
polysomnographic testing, we can only speculate about the
potential involvement of OSA in the association between NC
and MSNA in the present study. Notably, NC is more strongly
associated with OSA in men than women, which may be one
potential explanation for the gender differences observed in our
study (Lim et al., 2014).
Whilst no study to date has examined the relation of NC
to baroreflex function, it is recognized that visceral obesity
and the metabolic syndrome are associated with impairment
in baroreceptor ability to control heart rate and efferent
postganglionic sympathetic nerve traffic (Beske et al., 2002;
Grassi et al., 2005). Attenuation of these reflex mechanisms
stemming from carotid and aortic baroreceptors is thought
to play a causal role in the hyperadrenergic state typical of
the metabolic syndrome. In the present study we found no
relation between NC and spontaneous cardiac BRS, which
primarily reflects vagal efferent activity, in either men or women.
However, it merits emphasis that we did not analyse baroreceptor
modulation of MSNA, which may be of particular relevance.
Notably, in patients with OSA, impairment of baroreflex
sympathetic modulation is not accompanied by any impairment
in baroreflex control of heart rate (Narkiewicz et al., 1998b).
Dissimilarities in neck fat accumulation have been
demonstrated in men and women using positron emission
and computed tomography imaging. Overweight and obese
women have significantly higher neck subcutaneous fat and
significantly lower neck intermuscular adipose tissue compared
to age- and BMI-matched men (Torriani et al., 2014). Posterior
intermuscular and subcutaneous neck adipose tissue depots have
been linked with cardiometabolic risk (Torriani et al., 2014).
Moreover, NC is more closely related to abdominal visceral fat
in men than women (Li et al., 2014). A number of previous
studies, including our own work, support the notion that gender
influences the interaction between adiposity indices and SNS
activity. BMI and waist circumference are closely associated with
sympathetic nerve traffic in men but not women (Lambert et al.,
2007; Tank et al., 2008). The biological basis for these differences
is yet to be elucidated (Brooks et al., 2015). There are recognized
sex differences in the distribution, morphology and activity of
adipose tissue. Adipose tissue generates various signals that may
modulate sympathetic activity, including leptin, angiotensinogen
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TABLE 4 | Stepwise regression analyses of muscle sympathetic nerve
activity (MSNA) in men (n = 72).
Model Predictor variables Standardized
coefficients
Standard
error
R2 P
MSNA burst frequency (bursts/min)
1 Step 1 Neck circumference
(cm)
0.348 0.38 0.12 0.003
2 Step 1 Neck circumference
(cm)
0.295 0.38 0.12 0.01
Step 2 Log ALT (U/L) 0.249 6.13 0.18 0.03
3 Step 1 Neck circumference
(cm)
0.295 0.38 0.12 0.01
Step 2 Log ALT (U/L) 0.249 6.13 0.18 0.03
4 Step 1 Neck circumference
(cm)
0.312 0.39 0.14 0.006
Step 2 Insulin AUC0−120
(mU min L−1)
0.279 0.00 0.22 0.02
MSNA burst incidence (bursts/100 hb)
1 Step 1 Neck circumference
(cm)
0.262 0.57 0.07 0.03
2 Step 1 Neck circumference
(cm)
0.262 0.57 0.07 0.03
3 Step 1 Neck circumference
(cm)
0.262 0.57 0.07 0.03
4 Step 1 Neck circumference
(cm)
0.262 0.57 0.07 0.03
Model 1. Variables entered: neck circumference (cm), age (years).
Model 2. Variables entered: Model 1 and adiposity indices- BMI (kg/m2), waist
circumference (cm), log leptin (ng/ml), log ALT (U/L).
Model 3. Variables entered: Model 2 and lipid and blood pressure indices- LDL-C
(mmol/L), log HDL-C (mmol/L), log triglycerides (mmol/L), NEFA (mEq/L), systolic blood
pressure.
Model 4. Variables entered: Model 3 and indices of hyperinsulinemia and insulin
resistance- log Matsuda ISI, insulin AUC0−120 (mU min L
−1 ).
and NEFA, and there may be gender-specific differences in
the quantities produced and actions elicited on sympathetic
pathways (Brooks et al., 2015). For example, rodent studies
show that leptin’s sympathoexcitatory effects are exaggerated
in obese male animals, whereas in ovariactomized female rats,
intracerebroventricular leptin failed to alter lumbar sympathetic
nerve activity, unless the rats were given estrogen replacement
therapy (Shi and Brooks, 2015). In diet-induced obese mice,
weight gain was associated with increased plasma angiotensin
II in male, but not female animals (Gupte et al., 2012). Blunted
leptin-mediated sympathetic activation, quantified as whole-
body norepinephrine spillover rate, has also been linked to
leptin receptor polymorphisms, highlighting that genetic factors
may modulate the relation between adiposity hormones and
SNS activity (Masuo et al., 2008). As far as the present study
is concerned, we found positive associations between NEFA,
MSNA and NC, and leptin and NC in the men, but no further
relationships with other adiposity signals. Insulin resistance is
the primary mechanisms leading to greater free fatty acid release
in upper body obesity. Enhanced lipolysis produced by activation
of the SNS is another contributing factor. In turn, NEFA promote
insulin resistance via the Randle cycle and may thus increase
SNS activity indirectly (via hyperinsulinemia). Moreover, lipid
administration studies suggest that NEFA may also have direct
effects on α1-adrenoceptor sensitivity and central sympathetic
drive (Stepniakowski et al., 1995; Florian and Pawelczyk, 2010).
The strengths of our study include the use of un-
medicated subjects to avoid confounding by pharmacological
agents. Furthermore, microneurographic recordings are highly
reproducible within individuals and provide a direct measure
of postganglionic efferent nerve discharges leading to skeletal
muscle vasculature, which are of particular relevance to vascular
tone and glucose utilization (Fagius and Wallin, 1993; Jamerson
et al., 1993; Fairfax et al., 2013; Gamboa et al., 2014). Our
study also has several limitations. First, NC is a measure that
comprises both adipose and lean tissue and our study does not
distinguish between these compartments. Second, the sample size
was relatively small and we did not include any lean controls,
which would have enhanced the heterogeneity of the cohort,
and possibly the strength of associations. Third, a number of
unmeasured factors such as OSA, fitness level and androgenicity
may have influenced the relationships that were studied. Fourth,
we only examined sympathetic outflow to skeletal muscle but not
to other organs such as the kidneys, which are of relevance to the
development of hypertension and cardiovascular risk. Finally, the
cross-sectional design does not permit insight into causality.
In summary, within overweight and obese men NC was
associated with MSNA and features of insulin resistance
independent of central adiposity. In women NC was associated
with anthropometric measures but not with MSNA or metabolic
indices. Given the clinical relevance of chronic sympathetic
overactivity to future cardiovascular and metabolic disease
(Masuo et al., 1997; Schlaich et al., 2015; Wulsin et al., 2015),
NC may be a simple measure to aid risk stratification in at risk
overweight and obese men. Our data does not support its use in
women, beyond identifying overweight and obesity.
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